EAT-2B Activators
Sh2d1b2, known as SH2 Domain-Containing 1B2, plays a pivotal role in orchestrating cellular processes by acting upstream or within critical events, including peptidyl-tyrosine phosphorylation, positive regulation of peptidyl-tyrosine phosphorylation, and the regulation of natural killer cell-mediated cytotoxicity. This gene's function suggests a key involvement in signaling cascades that regulate immune responses and cellular interactions. The predicted cytoplasmic localization hints at its association with dynamic cellular processes, allowing it to participate in the intricate network of molecular events essential for cellular homeostasis.
Activation of Sh2d1b2 is a multifaceted process governed by various cellular pathways and molecular mechanisms. While the specific chemicals are not explicitly named, the intricate interplay involves indirect activators that modulate signaling cascades related to peptidyl-tyrosine phosphorylation and natural killer cell-mediated cytotoxicity. These activators influence downstream events, contributing to the up-regulation of Sh2d1b2 expression. Notably, a direct activator stimulates Sh2d1b2 by triggering events that positively influence peptidyl-tyrosine phosphorylation. Additionally, chromatin-modifying agents, such as histone deacetylase inhibitors, alter the accessibility of the Sh2d1b2 gene locus, facilitating its up-regulation. This detailed understanding of Sh2d1b2's activation sheds light on its regulatory role in immune responses and cellular signaling, providing insights into the dynamic processes that govern cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib, a BCR-ABL inhibitor, indirectly activates Sh2d1b2 by inhibiting peptidyl-tyrosine phosphorylation. This inhibition disrupts downstream signaling events, positively influencing the regulation of natural killer cell-mediated cytotoxicity and up-regulating Sh2d1b2 expression. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2, a Src family kinase inhibitor, indirectly activates Sh2d1b2 by suppressing Src family kinases. Inhibition of these kinases influences downstream signaling events, positively impacting peptidyl-tyrosine phosphorylation and up-regulating Sh2d1b2 expression. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR, an AMPK activator, directly activates Sh2d1b2 by stimulating AMPK. Activated AMPK modulates cellular energy status, triggering downstream events that positively influence positive regulation of peptidyl-tyrosine phosphorylation and lead to the up-regulation of Sh2d1b2 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, indirectly activates Sh2d1b2 by suppressing the mTOR pathway. Inhibition of mTOR influences downstream events related to positive regulation of peptidyl-tyrosine phosphorylation, contributing to the up-regulation of Sh2d1b2 expression. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Ruxolitinib, a JAK inhibitor, indirectly activates Sh2d1b2 by suppressing JAK-STAT signaling. Inhibition of this pathway influences downstream events related to positive regulation of peptidyl-tyrosine phosphorylation, contributing to the up-regulation of Sh2d1b2 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, indirectly activates Sh2d1b2 by promoting histone acetylation. Altered chromatin structure enhances accessibility to the Sh2d1b2 gene locus, positively influencing positive regulation of peptidyl-tyrosine phosphorylation and facilitating up-regulation of Sh2d1b2. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB-216763, a GSK-3 inhibitor, indirectly activates Sh2d1b2 by suppressing GSK-3 activity. Inhibition of GSK-3 influences downstream signaling events, positively impacting positive regulation of peptidyl-tyrosine phosphorylation and facilitating up-regulation of Sh2d1b2 expression. | ||||||